Akari Therapeutics Current Ratio vs. Current Valuation
| AKTX Stock | USD 1.30 0.06 4.84% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 0.94698953 | Current Value 0.9 | Quarterly Volatility 2.00927602 |
For Akari Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Akari Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Akari Therapeutics PLC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Akari Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Akari Therapeutics PLC over time as well as its relative position and ranking within its peers.
Akari |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akari Therapeutics. If investors know Akari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akari Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.58) | Return On Assets (1.73) | Return On Equity (12.81) |
The market value of Akari Therapeutics PLC is measured differently than its book value, which is the value of Akari that is recorded on the company's balance sheet. Investors also form their own opinion of Akari Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akari Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akari Therapeutics' market value can be influenced by many factors that don't directly affect Akari Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akari Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akari Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akari Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Akari Therapeutics PLC Current Valuation vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Akari Therapeutics's current stock value. Our valuation model uses many indicators to compare Akari Therapeutics value to that of its competitors to determine the firm's financial worth. Akari Therapeutics PLC is rated below average in current ratio category among its peers. It is rated below average in current valuation category among its peers reporting about 8,294,940 of Current Valuation per Current Ratio. At this time, Akari Therapeutics' Current Ratio is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akari Therapeutics' earnings, one of the primary drivers of an investment's value.Akari Current Valuation vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Akari Therapeutics |
| = | 3.73 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Akari Therapeutics |
| = | 30.94 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Akari Current Valuation vs Competition
Akari Therapeutics PLC is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 3.31 Billion. Akari Therapeutics maintains roughly 30.94 Million in current valuation contributing less than 1% to equities under Health Care industry.
Akari Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Akari Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Akari Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Akari Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Akari Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 51.2 M | 53.7 M | |
| Operating Income | -16.8 M | -17.6 M | |
| Income Before Tax | -10 M | -10.5 M | |
| Total Other Income Expense Net | 6.8 M | 7.1 M | |
| Net Loss | -10 M | -10.5 M | |
| Income Tax Expense | -9.7 M | -9.2 M | |
| Net Loss | -20.4 M | -21.4 M | |
| Net Loss | -20 M | -21 M | |
| Interest Income | 41.3 K | 39.3 K | |
| Net Interest Income | 41.3 K | 70.5 K | |
| Change To Netincome | 501.4 K | 476.4 K | |
| Net Loss | (2.04) | (2.15) | |
| Income Quality | 1.64 | 1.72 | |
| Net Income Per E B T | 0.45 | 0.89 |
Akari Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Akari Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Akari Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Akari Therapeutics' important profitability drivers and their relationship over time.
Use Akari Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akari Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will appreciate offsetting losses from the drop in the long position's value.Akari Therapeutics Pair Trading
Akari Therapeutics PLC Pair Trading Analysis
The ability to find closely correlated positions to Akari Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akari Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akari Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akari Therapeutics PLC to buy it.
The correlation of Akari Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akari Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akari Therapeutics PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akari Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Akari Therapeutics position
In addition to having Akari Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Crypto And Gold Thematic Idea Now
Crypto And Gold
Assets that cancel away each other volatility by providing diversification into gold investment combined with digital assets. The Crypto And Gold theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Crypto And Gold Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Akari Stock Analysis
When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.